July 7 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* ORBIMED ADVISORS- REPORTS STAKE IN FUSION PHARMACEUTICALS OF 7.2% AS OF JUNE 30, 2020 - SEC FILING
July 7 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* ORBIMED ADVISORS- REPORTS STAKE IN FUSION PHARMACEUTICALS OF 7.2% AS OF JUNE 30, 2020 - SEC FILING